Diagnostic Role of Metagenomic Next-Generation Sequencing in Tubercular Orthopedic Implant-Associated Infection
DOI: https://doi.org/10.2147/idr.s441940
2024-05-18
Infection and Drug Resistance
Abstract:Boyong Wang, 1, &ast Qiaojie Wang, 1, &ast Mingzhang Li, 1 Jinlong Yu, 1 Feng Jiang, 1 Yujie Hu, 1 Geyong Guo, 1 Xiaohua Chen, 2 Jin Tang, 3 Pei Han, 1 Hao Shen 1 1 Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China; 2 Department of Infectious Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China; 3 Clinical Laboratory, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hao Shen, Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China, Email Objective: The diagnosis of tubercular orthopedic implant-associated infection (TB-IAI) is challenging. This study evaluated the value of metagenomic next-generation sequencing (mNGS) for the diagnosis of TB-IAI and developed a standardized diagnostic procedure for TB-IAI. Methods: The records of all patients with TB-IAI diagnosed and treated at our institution between December 2018 and September 2022 were retrospectively reviewed. Patient demographic characteristics, medical history, laboratory test, microbial culture, histopathology, and mNGS results, and time to diagnosis were recorded. The diagnostic efficiency of mNGS for TB-IAI was assessed by comparing the results and diagnostic time with that of other diagnostic modalities. Results: Ten patients were included in the analysis, including eight with prosthetic joint infections and two with fracture-related infections. The mNGS positivity rate was 100% (10/10), which was higher than that of TB-antibody (11%, 1/9), real-time quantitative polymerase chain reaction (22%, 2/9), T-SPOT.TB (25%, 2/8), purified protein derivative (50%, 4/8), microbial culture (50%, 5/10), and histopathology (20%, 2/10). mNGS shortened the time to diagnosis of TB-IAI. A standardized diagnostic procedure for TB-IAI was developed based on the findings. Conclusion: mNGS is useful for the diagnosis of TB-IAI. mNGS is recommended in cases where it is difficult to identify a pathogen using routine diagnostic tests. The standardized diagnostic procedure might improve TB-IAI diagnosis. Importance: TB-IAI is a rare infection, which occurs after orthopedic surgery and hard to diagnose microbiologically. mNGS is a new detection technique not yet discussed in current literature as a means for TB-IAI diagnostics. Here we describe a cohort of patients with TB-IAI diagnosed by mNGS show high efficiency of mNGS for detection of this pathology and present a clinical algorithm supplementing conventional methods for TB-IAI assessment. Keywords: metagenomic next-generation sequencing, implant-associated infection, Mycobacterium tuberculosis complex, orthopedic infection, diagnosis Medical implants are widely used in orthopedic treatments. However, implant-associated infection (IAI) is a catastrophic complication of orthopedic surgery. 1 According to statistics, the incidence of IAI ranges from 1 to 30%. 2 Tubercular IAI (TB-IAI) is a rare infection caused by the Mycobacterium tuberculosis complex (MTBC), constituting approximately 0.14% of the cases of tuberculosis (TB). 3 Its incidence is very rare, and only a small number of cases have been reported in the literature to date. The low prevalence and lack of clinical suspicion may lead to a delay in the diagnosis or even misdiagnosis of TB-IAI, potentially resulting in multiple surgical procedures until MTBC is diagnosed. 4,5 It has been reported that the length of time until a diagnosis was made, ranged from 1 month to 3 years. 6 Mahale et al 7 reported 17 patients with implant-associated mycobacterium tuberculosis infection, of which 9 patients had delayed diagnosis (more than three months). Pathogen diagnosis is an important link in the diagnosis of IAI; however, negative pathogenic cultures often increase the difficulty in the diagnosis and treatment of the disease. The MTBC culture method is time-consuming and cultivation takes up to 2–8 weeks to produce results with a low positivity rate, so it is not useful for clinical guidance. 8 MTBC-specific diagnostic tests, such as TB-antibody (TB-Ab), real-time quantitative polymerase chain reaction (qPCR), the tuberculin p -Abstract Truncated-
pharmacology & pharmacy,infectious diseases